Old Web
English
Sign In
Acemap
>
authorDetail
>
Mira Swaminathan
Mira Swaminathan
Medicine
Crohn's disease
Internal medicine
Vedolizumab
Ustekinumab
4
Papers
14
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
P162 Comparative effectiveness of vedolizumab and ustekinumab in anti-TNF refractory Crohn’s disease: Multi-centre retrospective cohort study
2021
Gut
Tristan Townsend
Violeta Razanskaite
Stephanie Michail
James Morgan
Michael Davies
Daniel Storey
Christopher Watters
Douglas Penman
Mira Swaminathan
Ian Reilly
Paul K Flanagan
Sreedhar Subramanian
Show All
Source
Cite
Save
Citations (0)
P354 A multi-centre audit of lower gastrointestinal bleeding management
2021
Gut
Michael Davies
Tristan Townsend
Violeta Razanskaite
James Edwards Morgan
Daniyal Baig
James G. Fox
Vinay Kumar
Nada Elamin
Ioannis Papamargaritis
Zehra Zaidi
Heitham Zeglam
Doug Penman
Thomas Conley
Joe Fiske
Kieran Walker
Khoon Kok
Mira Swaminathan
Sreedhar Subramanian
Phil Smith
Show All
Source
Cite
Save
Citations (0)
Comparative effectiveness of ustekinumab or vedolizumab after one year in 130 patients with anti-TNF-refractory Crohn's disease.
2020
Alimentary Pharmacology & Therapeutics
Tristan Townsend
Violeta Razanskaite
Susanna Dodd
Daniel Storey
Stephanie Michail
James Morgan
Michael Davies
Douglas Penman
Christopher Watters
Mira Swaminathan
Joseph Sabine
Adam Chapman
Philip J Smith
Paul K Flanagan
Ian Reilly
Keith Bodger
Sreedhar Subramanian
Show All
Source
Cite
Save
Citations (14)
PTH-131 Multi-centre comparative effectiveness of vedolizumab and ustekinumab as induction therapy in anti-TNF refractory Crohn’s disease
2019
Gut
Violeta Razanskaite
Stephanie Michail
James Morgan
Michael Davies
Daneil Storey
Christopher Watters
Douglas Penman
Mira Swaminathan
Joseph Sabine
Adam Chapman
Ian Reilly
Paul Flanagan
Keith Bodger
Sreedhar Subramanian
Show All
Source
Cite
Save
Citations (0)
1